Meglumine Antimoniate

详情

Product Overview:
Meglumine Antimoniate is a potent antiprotozoal medication used in the treatment of leishmaniasis, a parasitic disease caused by protozoa from the *Leishmania* genus. This drug contains antimony, which targets and inhibits the growth of the parasites, providing an effective solution for managing various forms of leishmaniasis.
 
Key Features:
- Targeted Therapy: Specifically designed to combat *Leishmania* parasites, addressing the root cause of leishmaniasis.
- Proven Efficacy: Clinically demonstrated to reduce parasite burden and improve patient outcomes in leishmaniasis treatment.
- Intramuscular Administration: Administered via intramuscular injection, ensuring effective delivery of the medication.
 
Indications:
- Treatment of cutaneous, mucocutaneous, and visceral leishmaniasis.
 
Dosage and Administration:
- Dosage: The standard dosage typically ranges from *5 to *0 mg/kg of body weight per day, administered intramuscularly. The treatment duration is generally *0 days, but may vary based on the type and severity of leishmaniasis and individual patient factors.
- Administration: Administered by a healthcare professional, with careful monitoring for proper dosing and potential side effects.
 
Warnings:
- Monitoring: Regular monitoring of liver and kidney function is recommended, as Meglumine Antimoniate can affect these organs.
- Drug Interactions: Inform your healthcare provider of all concurrent medications and supplements to prevent potential interactions.
- Pregnancy and Breastfeeding: Consult your healthcare provider if you are pregnant, planning to become pregnant, or breastfeeding.
 
Side Effects:
- Common side effects may include nausea, vomiting, abdominal pain, and fatigue. Serious side effects, though less common, may involve liver toxicity, electrolyte imbalances, and allergic reactions. Immediate medical attention should be sought for any severe or persistent symptoms.
 
Storage:
- Store at room temperature, away from light and heat.
- Keep out of reach of children.
 
Packaging:
- Available in vials for intramuscular injection, with various concentrations to suit treatment needs.
 
Additional Information:
Meglumine Antimoniate is a critical medication for the effective management of leishmaniasis, offering targeted treatment to help control this parasitic infection. It is essential to use this medication under the guidance of a healthcare professional and to follow prescribed treatment regimens for the best outcomes.